{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:25:57Z","timestamp":1787199957721,"version":"build-2736575974"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intrahepatic adrenocortical adenoma (IAA) is a rare benign tumor that originates from ectopic adrenocortical tissue or adrenohepatic fusion. Due to its hypervascular enhancement pattern and tendency to occur in the right posterior liver, IAA may closely resemble hepatocellular carcinoma (HCC) on preoperative imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 67-year-old woman presented with intermittent right upper quadrant discomfort for 3 months. Despite the absence of viral hepatitis and normal tumor marker levels, contrast-enhanced magnetic resonance (MR) imaging showed a well-circumscribed hypervascular lesion in liver segments VI\/VII, with marked arterial phase hyperenhancement, relative portal venous phase hypoenhancement, and hypointensity during the hepatobiliary phase, initially creating an imaging appearance that raised concern for HCC. Contrast-enhanced computed tomography (CT) showed a low-attenuation lesion with a negative attenuation value on unenhanced images (-3 Hounsfield units), indicating lipid-rich content. Because malignancy could not be excluded, a laparoscopic partial hepatectomy was performed. Histopathology demonstrated an adrenocortical neoplasm composed of polygonal cells arranged in nests and cords. Immunohistochemistry was positive for steroidogenic factor-1, inhibin-alpha, and calretinin, whereas hepatocellular markers were negative. The final diagnosis was IAA. The postoperative course was uneventful, and no recurrence or metastasis was observed at 6-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IAA should be included in the differential diagnosis of hypervascular hepatic lesions adjacent to the right adrenal gland, especially in patients without typical HCC risk factors or tumor marker elevation. Increased awareness of this diagnostic pitfall is crucial for facilitating multidisciplinary assessment and enabling more individualized surgical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1890393","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:15:40Z","timestamp":1787199340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hypervascular lipid-rich intrahepatic adrenocortical adenoma in the right posterior liver: a diagnostic challenge for hepatobiliary surgeons"],"prefix":"10.3389","volume":"13","author":[{"given":"Shuqing","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People's Hospital","place":["Beijing, China"]},{"name":"Peking University Research Center for Diagnosis and Treatment of Liver Cancer","place":["Beijing, China"]},{"name":"Peking University Institute of Organ Transplantation","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People's Hospital","place":["Beijing, China"]},{"name":"Peking University Research Center for Diagnosis and Treatment of Liver Cancer","place":["Beijing, China"]},{"name":"Peking University Institute of Organ Transplantation","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People's Hospital","place":["Beijing, China"]},{"name":"Peking University Research Center for Diagnosis and Treatment of Liver Cancer","place":["Beijing, China"]},{"name":"Peking University Institute of Organ Transplantation","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People's Hospital","place":["Beijing, China"]},{"name":"Peking University Research Center for Diagnosis and Treatment of Liver Cancer","place":["Beijing, China"]},{"name":"Peking University Institute of Organ Transplantation","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People's Hospital","place":["Beijing, China"]},{"name":"Peking University Research Center for Diagnosis and Treatment of Liver Cancer","place":["Beijing, China"]},{"name":"Peking University Institute of Organ Transplantation","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"B3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.17998\/jlc.2025.07.29","article-title":"Preventing false positive imaging diagnosis of HCC: differentiating HCC from mimickers and practical strategies","volume":"25","author":"Joo","year":"2025","journal-title":"J Liver Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s43055-021-00657-0","article-title":"Hepatic adrenal rest tumor in a patient with multifactorial liver cirrhosis: a case report with CT and MRI findings and pathologic correlation","volume":"52","author":"Boraschi","year":"2021","journal-title":"Egypt J Radiol Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13000-021-01097-0","article-title":"An ectopic adrenocortical oncocytic adenoma in the liver highly mimicking hepatocellular carcinoma: case report and literature review","volume":"16","author":"Chen","year":"2021","journal-title":"Diagn Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4274\/jcrpe.galenos.2021.2021.0148","article-title":"Emergence of ectopic adrenal tissues-what are the probable mechanisms?","volume":"14","author":"Tar\u00e7\u0131n","year":"2022","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e31343","DOI":"10.7759\/cureus.31343","article-title":"Hepatic adrenal rest tumors mimicking hepatocellular carcinoma: a case report and review of the literature","volume":"14","author":"Al-Taee","year":"2022","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e15901","DOI":"10.1097\/MD.0000000000015901","article-title":"Intrahepatic adrenocortical adenoma arising from adrenohepatic fusion mimicking hepatic malignancy: two case reports","volume":"98","author":"Cho","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3348\/kjr.2010.11.1.126","article-title":"MDCT and Gd-EOB-DTPA enhanced MRI findings of adrenal adenoma arising from an ectopic adrenal gland within the liver: radiologic-pathologic correlation","volume":"11","author":"Yoon","year":"2010","journal-title":"Korean J Radiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/jpm11030208","article-title":"The role of immunohistochemical markers for the diagnosis and prognosis of adrenocortical neoplasms","volume":"11","author":"Angelousi","year":"2021","journal-title":"J Pers Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11154-025-09945-w","article-title":"The differential diagnosis of adrenocortical tumors: systematic review of ki-67 and IGF2 and meta-analysis of ki-67","volume":"26","author":"Oliveira","year":"2025","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1890393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:15:44Z","timestamp":1787199344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1890393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":12,"alternative-id":["10.3389\/fsurg.2026.1890393"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1890393","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1890393"}}